Staphylococcal infection

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II/III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II/III

1 trial
  • Centre Hospitalier Universitaire De Nantes Academic
    DALBAVANCIN
    2024-518183-12-00 1 country 2022 n=43
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Centre Hospitalier Universitaire De Nantes Academic 1 Phase II/III 0
New trials by year
2022
1
← All indication landscapes